Alkermes shareholders give green light to Elan DT merger
This article was originally published in Scrip
Executive Summary
The merger of Alkermes and Elan's drug formulation and manufacturing business, Elan Drug Technologies, is expected to complete next week after Alkermes's shareholders voted overwhelmingly in favour of the transaction.